Johnson & Johnson (JNJ)
NYSE
Real-time Data
01:30 PM
Day's Range
267.0052 wk Range
173.33Overview - JNJ - Johnson & Johnson
Key Statistics
Valuation
Enterprise Value
679.52B
P/E (Trailing)
‪31.35‬
P/E (Forward)
‪21.95‬
PEG Ratio
‪-274.23‬
Price / Sales (TTM)
‪6.65‬
Price / Book
‪7.65‬
EV / EBITDA
‪19.48‬
Profitability
Gross Margin
‪68.19%‬
Profit Margin
‪21.48%‬
Operating Margin
‪29.19%‬
Return on Assets
‪8.59%‬
Return on Equity
‪25.74%‬
Ownership
Shares Outstanding
2.40B
Float
2.40B
Short % of Shares Outstanding
‪1.17%‬
Held by Insiders
‪0.05%‬
Held by Institutions
‪76.90%‬
Price stats
Beta
‪0.23‬
50-Day Avg
‪254.83‬
200-Day Avg
‪231.81‬
Dividends
Payout Ratio
‪60.79%‬
Frequency
Quarterly
Analyst Consensus
23 analysts
Average price target
‪$ 272.50‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - JNJ - Johnson & Johnson
Peers - JNJ - Johnson & Johnson
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NYSE.
- JNJNYSEJohnson & Johnson651.25BMarket Cap+33.98%52-week change31.50P/E (Trailing)‪21.48%‬Profit Margin
- LLYNYSEEli Lilly and Company1.11TMarket Cap+44.61%52-week change42.21P/E (Trailing)‪33.52%‬Profit Margin
- ABBVNYSEAbbVie Inc.468.21BMarket Cap+21.67%52-week change75.06P/E (Trailing)‪9.80%‬Profit Margin
- MRKNYSEMerck & Co., Inc.376.36BMarket Cap+44.08%52-week change122.04P/E (Trailing)‪4.76%‬Profit Margin
- NVSNYSENovartis AG Sponsored ADR301.94BMarket Cap+21.29%52-week change24.00P/E (Trailing)‪22.50%‬Profit Margin
- SANNYSEBanco Santander S.A. Sponsored ADR212.65BMarket Cap+34.20%52-week change14.27P/E (Trailing)‪33.46%‬Profit Margin
- NVONYSENovo Nordisk A/S206.68BMarket Cap-20.54%52-week change11.59P/E (Trailing)‪35.34%‬Profit Margin
Profile Summary - JNJ - Johnson & Johnson
About
Johnson & Johnson is a holding company engaged in the research, development, manufacture, and sale of healthcare products worldwide. It operates through two primary segments: Innovative Medicine, which focuses on pharmaceuticals including treatments for immunology, oncology, infectious diseases, neuroscience,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
